Occupier

Find Out The Latest

Keep in touch with news and developments from The Oxford Science Park and its occupiers here.

You can also follow us on LinkedIn

“Vatic COVID-19 Home Spike Test” OTC EUA Submitted to FDA

16 Mar 2022

“Vatic COVID-19 Home Spike Test” OTC EUA Submitted to FDA Could Be Only Authorized SALIVA Rapid Test; Preferred to Nasal swabs by 4x in user testing OTC Self-Test Detects Virus Via ACE-2 Protein Binding to Trimeric Spike with Mouth Swab MARCH 16, 2022 – Vatic Health Limited (https://www.vatic.health/usa) today announces that it has submitted an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA)... Read more

Exscientia & University of Oxford Launch “Xcellomics” Program

10 Mar 2022

Exscientia and University of Oxford Launch “Xcellomics” Program to Expedite Early-Stage Academic Research and Translate Novel Biology Into Future Drug Discovery Program open at no-cost to any academic researcher interested in submitting a proposal OXFORD, England–(BUSINESS WIRE)– Exscientia (Nasdaq: EXAI) and the University of Oxford Target Discovery Institute (Oxford TDI) today announced the formation of Xcellomics – a... Read more

Renowned biotechnology exec & former Alnylam CEO John Maraganore has joined Evox Therapeutics

28 Feb 2022

Renowned biotechnology executive and former Alnylam CEO John Maraganore has joined Evox Therapeutics Ltd as an advisor. The company said – ‘We look forward to his counsel as we advance our exosome therapeutics programs in rare diseases.’ Read more

Enara Bio announces the appointment of T-cell therapy leader  Dr. Sophie Papa as Chief Medical Officer

01 Feb 2022

Enara Bio announces the appointment of T-cell therapy leader Dr. Sophie Papa as Chief Medical Officer Oxford, UK – 1st February 2022. Enara Bio, a biotechnology company advancing novel T-cell receptor (TCR) directed immunotherapies against unconventional, shared, cancer-specific antigens, announces the appointment of Dr. Sophie Papa, FRCP, PhD as Chief Medical Officer. Dr. Papa joins Enara Bio from King’s College London (KCL) and Guy’s... Read more

Exscientia & Sanofi Establish Collaboration to Develop AI-driven Pipeline of Medicines

07 Jan 2022

Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines January 7, 2022 * Collaborative efforts aim to accelerate drug discovery and improve clinical success * Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine platform from target identification through patient selection * Research will be focused on up to 15 novel small molecule... Read more

News